Ascletis Pharma Inc. (1672.HK) HKSE

13.65

+0.44(+3.33%)

Updated at December 05 04:09PM

Currency In HKD

Valuation

Market Cap2.83B
Enterprise Value1.97B
P/E Ratio-46.09
PEG Ratio-3.46
Price/Sales Ratio5,047.15
Price/Book Ratio6.38
Enterprise/Revenue4,380.45
Enterprise/EBITDA-25.37

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-109.38
Operating Margin-205.34

Management Effectiveness

Return On Assets-0.13
Return On Equity-0.13

Income Statement

Revenue1.28M
Revenue/Share0
Gross Profit735,000
EBITDA-390.45M
Net Income-300.94M
Diluted EPS-0.3

Balance Sheet

Total Cash1.8B
Total Cash/Share1.85
Total Debt4.27M
Total Debt/Equity0
Current Ratio14.57
Book Value Per Share1.94

Price History

52-Week Change670.62
52-Week High18.75
52-Week Low1.71
Moving Average 50 Days11.13
Moving Average 200 Days9.61

Statistics

Average Volume7.29M
Shares Outstanding963.58M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A